Delhi HC refuses to let ‘patent linkage’ in through the back door
The Delhi High Court on the 18th of this month in a judgment delivered by Justice Ravindra Bhat dismissing a writ petition filed by Bayer Corporation. Bayer Corporation sought to restrain the grant of a license under the Drugs and Cosmetics Act (henceforth referred to as Drugs Act) to Cipla for its drug “Soranib”. The landmark judgment also awarded costs amounting to Rs 6,75,000 which is payable in equal shares to the Union of India and Cipla. (There has been […]
Delhi HC refuses to let ‘patent linkage’ in through the back door Read More »

